Page last updated: 2024-10-20

phosphorylethanolamine and Neoplasm Metastasis

phosphorylethanolamine has been researched along with Neoplasm Metastasis in 2 studies

phosphorylethanolamine: RN given refers to parent cpd; structure
O-phosphoethanolamine : The ethanolamine mono-ester of phosphoric acid, and a metabolite of phospholipid metabolism. This phosphomonoester shows strong structural similarity to the inhibitory neurotransmitter GABA, and is decreased in post-mortem Alzheimer's disease brain.

Neoplasm Metastasis: The transfer of a neoplasm from one organ or part of the body to another remote from the primary site.

Research Excerpts

ExcerptRelevanceReference
"We show that murine renal carcinoma (Renca) is more sensitive to Pho-s when compared to normal immortalized rat proximal tubule cells (IRPTC) and human umbilical vein endothelial cells (HUVEC)."1.39Anti-angiogenic and anti-metastatic activity of synthetic phosphoethanolamine. ( Bydlowski, SP; Chierice, GO; Ferreira, AK; Filho, OM; Freitas, VM; Levy, D; Maria, DA; Rici, RE; Ruiz, JL, 2013)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mambelli, LI1
Teixeira, SF1
Jorge, SD1
Kawamura, B1
Meneguelo, R1
Barbuto, JAM1
de Azevedo, RA1
Ferreira, AK2
Freitas, VM1
Levy, D1
Ruiz, JL1
Bydlowski, SP1
Rici, RE1
Filho, OM1
Chierice, GO1
Maria, DA1

Other Studies

2 other studies available for phosphorylethanolamine and Neoplasm Metastasis

ArticleYear
Phosphoethanolamine induces caspase-independent cell death by reducing the expression of C-RAF and inhibits tumor growth in human melanoma model.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, Volume: 103

    Topics: Animals; Antineoplastic Agents; Apoptosis; Binding Sites; Caspases; Cell Cycle Checkpoints; Cell Mov

2018
Anti-angiogenic and anti-metastatic activity of synthetic phosphoethanolamine.
    PloS one, 2013, Volume: 8, Issue:3

    Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Renal Cell; Caspase 3

2013